Dr Iseult Browne: key facts
- Kind of voice
- Academic
- Role
- Clinical Research Fellow at The Institute of Cancer Research, London
- Quoted on
- Cancer
- Tracked press citations
- 2
- Most recently quoted
- 30 Sept 2026
“By analysing circulating tumour DNA in blood samples from patients with advanced breast cancer, we identified a clear link between these levels, both at the start and after one cycle of treatment, and how well patients responded to therapy. Patients with low or undetectable ctDNA consistently had better outcomes, including longer progression-free survival and higher response rates.”
What Dr Iseult Browne has said
“Our study shows that a simple blood test measuring circulating tumour DNA can provide an early prediction of whether a patients' breast cancer will respond to treatment. Knowing this at the earliest stage – in this case, at the start of treatment, or after just four weeks – means that we can avoid giving patients drugs that won't work and provide them with alternatives before their cancer has a chance to grow.”
clinical research fellow at the Institute of Cancer Research, London · Cancer · 27 Aug 2026 · Simple blood test can predict which breast cancer treatment will work best, study finds ↗
Where Dr Iseult Browne has been quoted
- Breast cancer blood test can predict treatment responseicr.ac.uk · 30 Sept 2026
- Simple blood test can predict which breast cancer treatment will work best, study findstheguardian.com · 27 Aug 2026
Related media coverage
Recent UK press coverage of their topics — not necessarily citing them directly.
Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 5 Oct 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.